This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The triglyceride and glucose (TyG) index, a simple surrogate marker of insulin resistance, is related to cardiovasculardisease. However, there is a lack of evidence for the relationship between the TyG index.
Cardiovasculardiseases (CVDs) have been reported to occur in a significant number of patients diagnosed with coronavirus disease 2019 (COVID-19). Cardiovascular consultation had been requested for all of the patients based on their primary clinical examination, vital signs, and electrocardiogram (ECG).
years]) admitted to the China ChestPain Center Database between 2016 and 2021. Hierarchical clustering of 15 medical conditions was performed to derive multimorbidity patterns. The primary outcome was a composite of inhospital adverse events.
Marcus, G. Harvard Medical School, Boston, Massachusetts, USA. Metoprolol and atenolol are overwhelmingly beta-1 cardioselective. Beta-1 blockade decreases inotropy and chronotropy and has no vasoconstrictive effects. Only beta-2 blockade (e.g., Hollander, J. de Lemos, J. Gibler, W. Philippides, G. Henry Ford Hospital. Hollander, J. de Lemos, J.
Risk of CardiovascularDisease by COVID-19 Can COVID-19 damage the heart? Yes, COVID-19, primarily a respiratory disease, can affect the heart. Yes, COVID-19 symptoms can resemble a heart attack, including chestpain, shortness of breath, and changes in echocardiogram or EKG. Risk posed by JN.1
The gradual loss of elasticity in arterial walls and the presence of other risk factors, such as high blood pressure and diabetes, contribute to the increased risk of cardiovasculardisease (CVD) observed in aging populations. years, 50% males) with known cardiovascular risk factors underwent FDG‐PET/CT.
This patient, who is a mid 60s female with a history of hypertension, hyperlipidemia and GERD, called 911 because of chestpain. A mid 60s woman with history of hypertension, hyperlipidemia, and GERD called 911 for chestpain. It is also NOT the clinical scenario of takotsubo (a week of intermittent chestpain).
IntroductionPatients with cognitive impairment often have a history of cardiovasculardisease (CVD) or multiple cardiovascular risk factors (CRFs) such as hypertension, obesity, and hypercholesterolemia. The literature reports that CVD with CRFs may increase the risk of developing vascular dementia and Alzheimer’s Disease.
A 70-something female with no previous cardiac history presented with acute chestpain. She awoke from sleep last night around 4:45 AM (3 hours prior to arrival) with pain that originated in her mid back. She stated the pain was achy/crampy. Over the course of the next hour, this pain turned into a pressure in her chest.
v As cardiovasculardisease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. CCTA offers a non-invasive, cost-effective, and highly sensitive method for diagnosing coronary artery disease (CAD), making it a valuable tool for clinicians.
Phosphodiesterase type 5 inhibitors (PDE5i)—an erectile dysfunction drug sold under the names Viagra, Levitra, Cialis, and others—are a common medical treatment for erectile dysfunction (ED) in men with cardiovasculardisease (CVD).
Within the complex umbrella of cardiovasculardisease, CAD is a type of heart disease that develops when the coronary arteries narrow and the heart cannot deliver enough oxygen-rich blood to the heart.
Submitted by Benjamin Garbus, MD with edits by Bracey, Meyers, and Smith A man in his early 30s presented to the ED with chestpain described as an “explosion" of left chest pressure. Pain largely resolved prior to EMS arrival but completely subsided after prehospital NTG and aspirin. Triage EKG: What do you think?
These conditions affect millions of individuals across the country each year, with more than 877,500 Americans experiencing symptoms related to heart disease, stroke, or other cardiovasculardiseases annually. About 276,000 patients have undergone a TAVR procedure in the United States.
More than 8 million Americans visit hospital emergency departments experiencing chestpain every year. Specifically, LODOCO reduces cardiac event risk in adult patients with established atherosclerotic cardiovasculardisease (ASCVD) by an additional 31% as compared to placebo. mg tablets.”
“We are witnessing a paradigm shift in how valvular heart diseases are diagnosed and treated,” said Partho Sengupta , Henry Rutgers Professor of Cardiology and chief of the Division of CardiovascularDisease and Hypertension at Rutgers Robert Wood Johnson Medical School.
Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as the primary testing strategy for patients with acute chestpain, are necessary for evaluating cases and determining treatment plans. Despite its importance, a substantial number of U.S.
An adult patient presented with palpitations, chestpain and reduced exertional capacity for 3 years. There was no family history of cardiovasculardisease or sudden cardiac death. Previously, the patient was an amateur weightlifter who used anabolic steroids but had ceased supplements 3 years before admission.
Understanding CardiovascularDisease in Women Understanding cardiovasculardisease in women involves recognizing unique risk factors such as hormonal changes and pregnancy-related complications, necessitating proactive care and awareness to manage and prevent heart disease effectively.
The American Heart Association’s scientific statement, “Psychological Health, Well-Being, and the Mind-Heart-Body Connection,” emphasizes the need to evaluate and address psychological health in patients with or at risk for cardiovasculardisease (CVD).
The BoardVitals Cardiology Question Bank has more than 1,400 review questions to help you prepare for the CardiovascularDisease Board Exam and Cardiology MOC. ACS QID 3103 A 64 year old Caucasian male with a history of extensive tobacco use, hypertension, hyperlipidemia, and obesity presents with acute onset chestpain.
Below, we aim to debunk common myths about cardiovasculardisease, providing accurate information and emphasizing the importance of treatment for heart disease with timely interventions. However, seeking immediate medical help is crucial if you experience chestpain, shortness of breath or dizziness.
His medical history is unremarkable except a similar pain occurred 4-5 times in the previous 3 months with less intensity, short duration, unrelated to exertion. There was no premature cardiovasculardiseases or sudden death in his family. He has 40 packs-year of smoking history. He denies taking any medication.
Main outcome measures All-cause, HF and non-cardiovasculardisease (non-CVD) hospitalisation and mortality. Generic symptoms also showed significant associations: depression (1.50; 1.18, 1.82), anxiety (1.35; 1.06, 1.64) and pain (1.19; 1.10, 1.28). Controls could be included more than once and later become a case.
Erectile dysfunction (ED) is a common concern among men, especially those dealing with cardiovasculardisease. The connection between heart health, vascular risk factors, and sexual function is well-documented, with poor cardiovascular health often leading to or exacerbating erectile issues.
Share The standard stress test involves a protocol of a patient exercising at progressively higher workloads until a predetermined endpoint, either a target heart rate, suspicious ECG changes or the occurrence of chestpain, etc. 4 Changes in Cardiorespiratory Fitness and Survival in Patients With or Without CardiovascularDisease.
And sex-specific cardiovascular education of trainees and the entire care team is imperative," says Laxmi Mehta, MD, FACC, director of preventive cardiology and women's cardiovascular health at The Ohio State University Wexner Medical Center in Columbus. We need to learn the tools and how to deal with that anxiety well." "In
Check : [vitals, SOB, ChestPain, Ultrasound] If the patient has Abdominal Pain, ChestPain, Dyspnea or Hypoxemia, Headache, Hypotension , then these should be considered the primary chief complaint (not syncope). Aortic Dissection, Valvular (especially Aortic Stenosis), Tamponade. g/dL Hypotension (obviously!)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content